12th Microsymposium on Small RNAs at the Vienna BioCenter
The “12th Microsymposium on Small RNAs” has started at the Vienna BioCenter (VBC) today.
Featuring some of the leading scientists in the field from around the world, the symposium is running from May 26th to 28th 2017 at the VBC, sponsored by three research institutes - IMBA, IMP and GMI.
The symposium has a strong tradition and brings together scientists in the broad field of small RNA biology, but also related RNA fields. It has an emphasis on junior PIs, postdocs, and PhD students.
Over the years, the “Microsymposium on Small RNAs” has developed into one of the most prestigious meetings in this field, and especially the open and dynamic atmosphere of the meeting make it a great event.
This annual occasion also strengthens the global recognition of RNA biology research done at the Vienna BioCenter; this subject links several research groups from all four VBC-based research institutes and has developed into one of the core strengths of the VBC. The symposium is in fact co-organised by group leaders from all four institutions: Stefan Ameres and Julius Brennecke (both IMBA), Luisa Cochella (IMP), Javier Martinez (MFPL) and Michael Nodine (GMI).
More information: http://www.imba.oeaw.ac.at/news-events/events/microsymposium/
University of Copenhagen, Denmark
CNRS, Montpellier, France
Institute of Molecular Pathology (IMP), Austria
Sheba Medical Center affiliated with Tel-Aviv University
University of California, Riverside, USA
Brandeis University, United States
Harvard Medical School, United States
Cold Spring Harbor Laboratory, United States
IMB Mainz, Germany
Keio University School of Medicine, Japan
The Ohio State University, United States
Indiana University, Bloomington, United States
Katalin Fejes Tóth
Caltech, United States
Weizmann Institute of Science, Israel
Max Planck Institute, Germany
Montana State University, United States
University of Basel, Switzerland
UC Berkeley, United States
About the Vienna BioCenter
The Vienna BioCenter (VBC) is a leading life sciences location in Europe, offering an extraordinary combination of research, education and business on a single campus. About 1,600 employees, more than 1,000 students, 93 research groups, 16 biotech companies, and scientists from more than 40 nations create a highly dynamic environment. See: http://www.viennabiocenter.org
About the IMP
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 37 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.